PLoS ONE,
Год журнала:
2023,
Номер
18(4), С. e0284075 - e0284075
Опубликована: Апрель 7, 2023
Prolonged
symptoms
of
COVID-19
have
been
found
in
many
patients,
often
known
as
Long
COVID.
Psychiatric
are
commonly
seen
COVID
patients
and
could
last
for
weeks,
even
months,
after
recovery.
However,
the
risk
factors
associated
with
it
remain
unclear.
In
current
systematic
review,
we
provide
an
overview
psychiatric
development
those
symptoms.
Articles
were
systematically
searched
on
SCOPUS,
PubMed,
EMBASE
up
to
October
2021.
Studies
involving
adults
geriatric
participants
a
confirmed
previous
diagnosis
reported
that
persist
more
than
four
weeks
initial
infection
included.
The
bias
was
assessed
using
Newcastle-Ottawa
Scale
(NOS)
observational
studies.
Prevalence
rates
collected.
This
present
study
registered
at
PROSPERO
(CRD42021240776).
total,
23
studies
Several
limitations
this
review
heterogeneity
studies’
outcomes
designs,
limited
articles
published
English,
mainly
self-report
questionnaires.
most
prevalent
symptoms,
from
least
reported,
anxiety,
depression,
post-traumatic
stress
disorder
(PTSD),
poor
sleep
qualities,
somatic
cognitive
deficits.
Being
female
having
diagnoses
Neurology International,
Год журнала:
2023,
Номер
15(3), С. 821 - 841
Опубликована: Июль 6, 2023
SARS-CoV-2,
a
single-stranded
RNA
coronavirus,
causes
an
illness
known
as
coronavirus
disease
2019
(COVID-19).
Long-term
complications
are
increasing
issue
in
patients
who
have
been
infected
with
COVID-19
and
may
be
result
of
viral-associated
systemic
central
nervous
system
inflammation
or
arise
from
virus-induced
hypercoagulable
state.
incite
changes
brain
function
wide
range
lingering
symptoms.
Patients
often
experience
fatigue
note
fog,
sensorimotor
symptoms,
sleep
disturbances.
Prolonged
neurological
neuropsychiatric
symptoms
prevalent
can
interfere
substantially
everyday
life,
leading
to
massive
public
health
concern.
The
mechanistic
pathways
by
which
SARS-CoV-2
infection
sequelae
important
subject
ongoing
research.
Inflammation-
induced
blood-brain
barrier
permeability
viral
neuro-invasion
direct
nerve
damage
involved.
Though
the
mechanisms
uncertain,
resulting
documented
numerous
patient
reports
studies.
This
review
examines
constellation
spectrum
seen
long
COVID
incorporates
information
on
prevalence
these
contributing
factors,
typical
course.
Although
treatment
options
generally
lacking,
potential
therapeutic
approaches
for
alleviating
improving
quality
life
explored.
Journal of Neuroinflammation,
Год журнала:
2025,
Номер
22(1)
Опубликована: Фев. 15, 2025
Cerebral
endothelial
cells
(CEC)
that
form
the
brain
capillaries
are
principal
constituents
of
blood
barrier
(BBB),
main
active
interface
between
and
which
plays
a
protective
role
by
restricting
infiltration
pathogens,
harmful
substances
immune
into
while
allowing
entry
essential
nutrients.
Aberrant
CEC
function
often
leads
to
increased
permeability
BBB
altering
bidirectional
communication
bloodstream
facilitating
extravasation
brain.
In
addition
their
as
gatekeepers
BBB,
exhibit
cell
properties
they
can
receive
transmit
signals
partly
via
release
inflammatory
effectors
in
pathological
conditions.
express
innate
receptors,
including
toll
like
receptors
(TLRs)
inflammasomes
first
sensors
exogenous
or
endogenous
dangers
initiators
responses
drive
neural
dysfunction
degeneration.
Accumulating
evidence
indicates
activation
TLRs
compromises
integrity,
promotes
aberrant
neuroimmune
interactions
modulates
both
systemic
neuroinflammation,
common
features
neurodegenerative
psychiatric
diseases
central
nervous
system
(CNS)
infections
injuries.
The
goal
present
review
is
provide
an
overview
pivotal
roles
played
discuss
molecular
cellular
mechanisms
contribute
disruption
neuroinflammation
especially
context
traumatic
ischemic
injuries
infections.
We
will
focus
on
most
recent
advances
literature
reports
field
highlight
knowledge
gaps.
future
research
directions
advance
our
understanding
contribution
potential
at
promising
therapeutic
targets
wide
variety
conditions
The Lancet Psychiatry,
Год журнала:
2022,
Номер
9(11), С. 894 - 906
Опубликована: Окт. 14, 2022
Evidence
on
associations
between
COVID-19
illness
and
mental
health
is
mixed.
We
aimed
to
examine
whether
associated
with
deterioration
in
while
considering
pre-pandemic
health,
time
since
infection,
subgroup
differences,
confirmation
of
infection
via
self-reported
test
serology
data.We
obtained
data
from
11
UK
longitudinal
studies
repeated
measures
(psychological
distress,
depression,
anxiety,
life
satisfaction;
scales
were
standardised
within
each
study
across
time)
status
April,
2020,
2021.
included
participants
information
available
at
least
one
outcome
measure
(suspected
or
test-confirmed)
during
the
pandemic,
a
subset
serology-confirmed
COVID-19.
Furthermore,
only
who
had
minimum
set
covariates,
including
age,
sex,
included.
investigated
having
ever
outcomes
using
generalised
estimating
equations.
examined
varied
by
ethnicity,
education,
strength
association
according
differed
versus
confirmed
(by
serology)
infection.Between
21
Dec,
2021,
July
11,
2022,
we
analysed
54
442
(ranging
age
16
years
maximum
category
90
older
another;
33
200
[61·0%]
women
242
[39·0%]
men)
studies.
Of
40
819
ethnicity
data,
36
802
(90·2%)
White.
Pooled
estimates
differences
suggested
subsequent
psychological
distress
(0·10
[95%
CI
0·06
0·13],
I2=42·8%),
depression
(0·08
[0·05
0·10],
I2=20·8%),
anxiety
I2=0·0%),
lower
satisfaction
(-0·06
[-0·08
-0·04],
I2=29·2%).
found
no
evidence
interactions
health.
Associations
did
not
vary
substantially
less
than
4
weeks,
4-12
more
12
present
all
groups,
some
stronger
effects
those
aged
50
older.
Participants
but
negative
worse
for
without
based
self-report.
positive
self-report
show
outcomes.Self-reporting
was
longitudinally
satisfaction.
Our
findings
emphasise
need
greater
post-infection
service
provision,
given
substantial
prevalence
worldwide.UK
Medical
Research
Council
National
Institute
Health
Care
Research.
Neurology and Therapy,
Год журнала:
2022,
Номер
11(4), С. 1637 - 1657
Опубликована: Авг. 26, 2022
The
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
can
affect
multiple
organs.
Reports
of
persistent
or
newly
emergent
symptoms,
including
those
related
to
the
nervous
system,
have
increased
over
course
pandemic,
leading
introduction
post-COVID-19
syndrome.
However,
this
novel
is
still
ill-defined
and
structured
objectification
complaints
scarce.
Therefore,
we
performed
a
prospective
observational
cohort
study
better
define
validate
subjective
neurological
disturbances
in
patients
with
syndrome.A
total
171
fulfilling
WHO
Delphi
consensus
criteria
underwent
comprehensive
diagnostic
work-up
neurovascular,
electrophysiological,
blood
analysis.
In
addition,
magnetic
resonance
imaging
(MRI)
lumbar
puncture
were
conducted
subgroups
patients.
Furthermore,
neuropsychological,
psychosomatic,
fatigue
assessment.Patients
predominantly
female,
middle-aged,
had
incurred
mostly
mild-to-moderate
COVID-19.
most
frequent
included
fatigue,
difficulties
concentration,
memory
deficits.
(85.8%),
in-depth
assessment
yielded
no
pathological
findings.
97.7%
cases,
either
diagnosis
other
than
post
COVID-19
syndrome,
likely
preceding
could
be
established.
Sensory
motor
more
often
associated
Previous
psychiatric
conditions
identified
as
risk
factor
for
developing
We
found
high
somatization
scores
our
patient
group
that
correlated
cognitive
deficits
extent
fatigue.Albeit
frequently
reported
by
patients,
objectifiable
affection
system
rare
Instead,
elevated
levels
point
towards
pathogenesis
potentially
involving
psychosomatic
factors.
thorough
important
order
not
miss
diseases
post-COVID-19.
Psychiatry Research,
Год журнала:
2022,
Номер
317, С. 114836 - 114836
Опубликована: Сен. 6, 2022
Neuropsychiatric
symptoms
are
the
most
common
sequelae
of
long-COVID.
As
accumulating
evidence
suggests
an
impact
survived
SARS-CoV-2-infection
on
brain
physiology,
it
is
necessary
to
further
investigate
structural
changes
in
relation
course
and
neuropsychiatric
symptom
burden
To
this
end,
present
study
investigated
3T-MRI
scans
from
long-COVID
patients
suffering
(n
=
30),
healthy
controls
20).
Whole-brain
comparison
gray
matter
volume
(GMV)
was
conducted
by
voxel-based
morphometry.
determine
whether
GMV
predicted
and/or
initial
severity
COVID-19
time
since
onset
stepwise
linear
regression
analysis
performed.
Significantly
enlarged
several
clusters
(spanning
fronto-temporal
areas,
insula,
hippocampus,
amygdala,
basal
ganglia,
thalamus
both
hemispheres)
when
compared
controls.
Time
a
significant
regressor
four
these
with
inverse
relationship.
No
associations
clinical
were
found.
alterations
limbic
secondary
olfactory
areas
might
be
dynamic
over
time.
Larger
samples
longitudinal
data
required
clarify
mediating
mechanisms
between
COVID-19,
symptoms.
International Journal of Infectious Diseases,
Год журнала:
2022,
Номер
125, С. 287 - 293
Опубликована: Окт. 1, 2022
To
describe
long-COVID
symptoms
among
older
adults
and
to
assess
the
risk
factors
for
two
common
symptoms:
fatigue
dyspnea.This
is
a
multicenter,
prospective
cohort
study
conducted
in
Israel,
Switzerland,
Spain,
Italy.
Individuals
were
included
at
least
30
days
after
their
COVID-19
diagnosis.
We
compared
between
elderly
(aged
>65
years)
younger
individuals
18-65
univariate
multivariable
analyses
predictors
of
dyspnea.A
total
2333
evaluated
an
average
5
months
(146
[95%
confidence
interval
142-150])
onset.
The
mean
age
was
51
years,
20.5%
aged
years.
Older
more
likely
be
symptomatic,
with
most
being
(38%)
dyspnea
(30%);
they
complain
cough
arthralgia
have
abnormal
chest
imaging
pulmonary
function
tests.
Independent
female
gender,
obesity,
closer
proximity
diagnosis;
not
independent
predictor.Older
different
persisting
symptoms,
pronounced
impairment.
Women
obesity
are
risk.
Further
research
warranted
investigate
natural
history
population
possible
interventions
aimed
promoting
rehabilitation
well-being.
JAMA Psychiatry,
Год журнала:
2022,
Номер
79(8), С. 811 - 811
Опубликована: Июнь 29, 2022
Importance
Neuropsychiatric
symptoms
have
been
reported
as
a
prominent
feature
of
postacute
sequelae
COVID-19
(PASC),
with
common
that
include
cognitive
impairment,
sleep
difficulties,
depression,
posttraumatic
stress,
and
substance
use
disorders.
A
primary
challenge
parsing
PASC
epidemiology
pathophysiology
is
the
lack
standard
definition
syndrome,
little
known
regarding
mechanisms
neuropsychiatric
PASC.
Observations
Rates
symptom
prevalence
vary,
but
at
least
1
has
in
many
90%
patients
6
months
after
hospitalization
approximately
25%
nonhospitalized
adults
COVID-19.
Mechanisms
are
still
being
elucidated.
They
may
static
brain
injury
accrued
during
acute
COVID-19,
neurodegeneration
triggered
by
secondary
effects
autoimmune
chronic
inflammation,
viral
persistence
tissue
reservoirs,
or
reactivation
other
latent
viruses.
Despite
rapidly
emerging
data,
gaps
knowledge
persist
related
to
variable
definitions
PASC,
standardized
phenotyping
biomarkers,
variability
virus
genotypes,
ascertainment
biases,
limited
accounting
for
social
determinants
health
pandemic-related
stressors.
Conclusions
Relevance
Growing
data
support
high
symptoms,
current
literature
heterogeneous
assessments
critical
epidemiological
factors.
By
enrolling
large
patient
samples
conducting
state-of-the-art
assessments,
Researching
COVID
Enhance
Recovery
(RECOVER),
multicenter
research
initiative
funded
National
Institutes
Health,
will
help
clarify
epidemiology,
pathophysiology,
injury,
well
identify
targets
therapeutic
intervention.